Antiviral therapy improves survival rates for kidney transplant recipients with hepatitis B or C
Prior to the development of antiviral therapy, kidney transplant recipients infected with either hepatitis B (HBV) or hepatitis C (HCV) experienced poor outcomes. In a new study in the Journal of Hepatology, researchers report ...
Mar 14, 2019
0
1